TAFRO-like syndrome associated with long-term CAR-T cell persistence after axicabtagene ciloleucel therapy

July 23, 2026HaematologicaOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to examine the correlation between long-term CAR-T cell persistence and the development of TAFRO-like syndrome.
Clinical evaluation of patients receiving axicabtagene ciloleucel therapy for CAR-T cell treatment.
Monitoring for symptoms of TAFRO-like syndrome during and after therapy.
Analysis of cytokine levels and immune responses post-treatment.
Patients exhibited symptoms consistent with TAFRO-like syndrome post-therapy.
Long-term CAR-T cell persistence was observed in patients presenting these symptoms.
Association noted between cytokine release and TAFRO-like syndrome occurrence.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Clinical observations show TAFRO-like syndrome develops following CAR-T cell therapy, suggesting monitoring may be crucial.

No takes yet. Share an insight, caveat, or question.

Mirete et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share